Page 6 - Astrazeneca

One shot of Pfizer, AstraZeneca vax offers 60% protection against Covid

A single dose of either the Pfizer or AstraZeneca Covid-19 vaccine offers around 60 per cent protection against infection from SARS-CoV-2, the virus causing Covid-19, in adults aged 65 years and above

30 to 40 countries unable to give second Covid-19 shots: WHO official

Between 30 to 40 countries are unable to provide second doses of a Covid-19 vaccine, especially those expecting jabs from AstraZeneca, officials of the World Health Organization (WHO) said.

WHO working with AstraZeneca, SII, Indian govt to restart vax shipment

The WHO is urgently trying to work with AstraZeneca, Serum Institute of India (SII) as well as the Indian government to restart shipments of Covid-19 vaccines to countries

AstraZeneca ordered to deliver 50mn Covid-19 vaccine doses or face fines

A Brussels court has ordered AstraZeneca to deliver an additional 50 million doses of Covid-19 vaccines to EU member states by September or face a maximum of 500 mn euros ($593 mn) in fines

AstraZeneca claims victory in tussle with European Union over deliveries

AstraZeneca now looks forward to renewed collaboration with the European Commission to help combat the pandemic in Europe.

AstraZeneca Covid-19 vaccine faces more supply hurdles, now from Thailand

Thailand was slated to receive and administer 6 million AstraZeneca vaccine doses in June but health authorities this week said they would be distributing only 3.5 million of those shots this month

Pfizer, Moderna preferred 2nd dose after AstraZeneca: Canadian authorities

Canada's National Advisory Committee on Immunization said Thursday people who got the AstraZeneca vaccine as their first dose should get Pfizer-BioNTech or Moderna for their second shot

AstraZeneca's antibody cocktail fails to prevent Covid-19 in latest trial

The trial of 1,121 adult volunteers looked at whether the long-acting antibody combination could protect people who had recently been in contact with the SARS-CoV-2 virus in places like care homes.

Risk of hospitalisation doubles with Delta versus Alpha variant: Study

Vaccines from Pfizer Inc. and AstraZeneca Plc protect against delta, researchers said Monday

Italy suspends use of AstraZeneca vaccine for people under 60 year old

Italy on Friday suspended the use of the AstraZeneca vaccine for people under 60 years old, health officials announced at a weekly press conference on the Covid-19 pandemic

EU adds another rare blood condition as side effect of AstraZeneca shot

Cites another rare blood condition as side effect

Centre fixes maximum price for Covid-19 vaccines at private hospitals

The CoWIN system would also ensure that the prices declared by various private vaccination centres do not exceed the maximum price

Govt caps maximum price of Covishield, Covaxin, Sputnik V for pvt hospitals

The govt has set the maximum price private hospitals can charge for the three Covid vaccines currently available in the country -- Covishield Rs 780 per dose, Covaxin Rs 1,410, and Sputnik V Rs 1,145

India Coronavirus Dispatch: Daily infections retreat to 61-day low

Centre 'willing' to rethink vaccine procurement policy, six UP districts among those with the lowest vaccination coverage, and more-news relevant to India's fight against the pandemic

US will share a 'substantial' number of Covid-19 vaccine doses with India

Exact number yet to be frozen; first tranche of 25 mn shots earmarked from Asia, LatAm, Africa

Japan enters Taiwan-China fight with Covid-19 vaccine shipments to Taipei

Donating the vaccines to Taiwan could irritate China, Japan's biggest trading partner.

AstraZeneca vax 2nd dose FAQs about blood clots, safety, risks and symptoms

Rare but serious blood clots that have been linked the AstraZeneca Covid-19 vaccine have many people especially those who have already had one dose of the vaccine looking for information

European Union takes on AstraZeneca in court over vaccine deliveries

The long-standing dispute drew media attention for weeks earlier this year amid a deadly surge of coronavirus infections in Europe

AstraZeneca Pharma India Q4 net profit up nearly 3-fold to Rs 27.27 cr

Drug firm AstraZeneca Pharma India on Tuesday reported a nearly three-fold jump in its net profit to Rs 27.27 crore for the quarter ended March 31, 2021. The company had posted a net profit of Rs 9.57 crore for the corresponding period of the previous fiscal, AstraZeneca Pharma India said in a regulatory filing. Revenue from operations of the company stood at Rs 210.25 crore for the quarter under consideration. It was Rs 194.90 crore for the same period a year ago, it added. For the financial year ended March this year, the net profit of the company was Rs 93.30 crore as against Rs 72.22 crore for the previous financial year, the filing said. The company's revenue from operations stood at Rs 813.56 crore for the financial year ended March 31, 2021. It was Rs 831.80 crore for the year-ago fiscal, it added. Shares of AstraZeneca Pharma India closed at Rs 3,862.45 per scrip on BSE, up 0.84 percent from its previous close.

Delhi yet to receive more Covid-19 vaccines for 18-44 group, says Atishi

Delhi is yet to receive more vaccines for the 18-44 age group and only private hospitals are giving jabs to beneficiaries in this category for now, Aam Aadmi Party MLA Atishi said on Tuesday